Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

The Lancet · 1997 · 2.5K citations · Full text

Medicine, Endocrinology, Oncology +15

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

Graham A. Colditz, Susan E. Hankinson, David J. Hunter et al. · New England Journal of Medicine · 1995 · 1.5K citations · Full text

Medicine, Endocrinology, Oncology +14

Breast cancer screening with mammography: overview of Swedish randomised trials

L. Nyström, Stig Wall, L. E. Rutqvist et al. · The Lancet · 1993 · 978 citations

Medicine, Preventive Medicine, Radiology +12

The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement

Leif Bergkvist, Hans‐Olov Adami, Ingemar Persson et al. · New England Journal of Medicine · 1989 · 619 citations

Medicine, Endocrinology, Oncology +13

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

TJA Key, MC Pike · British Journal of Cancer · 1988 · 550 citations · Full text

Medicine, Gynecology, Oncology +15